COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 10:45, il y a 8 mois 13 jours Des privilèges exceptionnels pour les familles en Thaïlande – Août à septembre 2025 La Thaïlande lance la campagne 'Thai'd Up This Summer' offrant des offres spéciales aux familles voyageant en août et septembre 2025. Pour plus d'informations, visitez le site www.tourismthailand.org/amazinggrandprivileges Tourisme Thaïlande Offres Spéciales Familles Campagne
COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 10:07, il y a 8 mois 13 jours H&R GmbH & Co. KGaA confirms Figures for First Half-Year of 2025 H&R GmbH & Co. KGaA confirms first half-year 2025 figures with sales revenue of EUR 653.1 million, slightly below previous year. Adjusts 2025 guidance to €77.0-€90.0 million range Sales Revenue H&R GmbH & Co. KGaA First Half-Year 2025 Guidance 2025 Figures
COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 10:05, il y a 8 mois 13 jours annual press conference – preliminary results fiscal year 2024/2025 Borussia Dortmund GmbH & Co. KGaA to hold annual press conference on preliminary results for fiscal year 2024/2025. Live stream available online Preliminary Results Borussia Dortmund Fiscal Year Press Conference Annual
COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 09:01, il y a 8 mois 13 jours Original-Research: DEMIRE AG (von NuWays AG): BUY Research update on DEMIRE AG by NuWays AG reports Q2 results, with rental income meeting expectations and FFO exceeding estimates. Company upgrades FY25 guidance. Shares undervalued DEMIRE AG NuWays AG Research Update Q2 Results FFO Guidance
COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 09:00, il y a 8 mois 13 jours Original-Research: LION E-Mobility AG (von NuWays AG): BUY Research update on LION E-Mobility AG by NuWays AG highlights positive H1 results, operational turnaround, new partnerships, and growth prospects. Target price: EUR 2.90. Strategic focus on BESS and energy storage market LION E-Mobility AG Energy Storage Market NuWays AG Research Update Operational Turnaround
COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 09:00, il y a 8 mois 13 jours Original-Research: DO & CO AG (von NuWays AG): BUY NuWays AG updates research on DO & CO AG with BUY recommendation and increased target price after strong Q1 results showing growth across all segments and record EBIT. Company expects continued momentum with higher margins NuWays AG Research Update Q1 Results DO & CO AG EBIT Record
COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 09:00, il y a 8 mois 13 jours Original-Research: Semperit AG Holding (von NuWays AG): BUY NuWays AG Research recommends BUY rating for Semperit AG Holding due to Q2 performance and confirmation of FY25 guidance. Improved margins and strong balance sheet enhance growth prospects NuWays AG BUY Rating Research Semperit AG Holding Q2 Performance
COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 09:00, il y a 8 mois 13 jours Original-Research: MLP SE (von NuWays AG): BUY NuWays AG releases an update research report on MLP SE, confirming a 'BUY' recommendation with a target price of EUR 13.00. Q2 results show mixed sales performance but in line with estimates, maintaining FY'25 EBIT guidance of €100-110m NuWays AG MLP SE Q2 Results Research Report FY'25 EBIT Guidance
COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 09:00, il y a 8 mois 13 jours SANHA GmbH & Co. KG reports solid business performance in the first half of 2025 SANHA GmbH & Co. KG reports stable business performance in the first half of 2025 with revenue at EUR 61.5 million. Gross profit increased, EBITDA margin slightly down. Outlook confirms stable performance Revenue EBITDA Margin Outlook Business Performance SANHA GmbH
COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 08:30, il y a 8 mois 13 jours clearvise increases earnings in the first half of 2025 and confirms outlook despite challenging market conditions clearvise AG increases earnings in the first half of 2025 by 5% to EUR 13.6 million despite challenging market conditions. Total production 220.0 GWh, outlook for 2025 confirmed Clearvise AG Renewable Energies Earnings Increase 2025 Financial Report Outlook Confirmation
Publié le 28/04/2026 à 07:20, il y a 6 heures 30 minutes Growth, Performance and Record Investments: Air Liquide continues on its successful trajectory in Q1 2026
Publié le 28/04/2026 à 07:20, il y a 6 heures 30 minutes Croissance, Performance, et Investissements records : Air Liquide poursuit avec succès sa trajectoire au T1 2026
Publié le 27/04/2026 à 17:45, il y a 20 heures 5 minutes Oproeping tot de jaarlijkse algemene vergadering van 27 mei 2026
Publié le 27/04/2026 à 17:45, il y a 20 heures 5 minutes Convocation annual general meeting of May 27, 2026
Publié le 27/04/2026 à 17:45, il y a 20 heures 5 minutes Déclaration hebdomadaire de rachat d'actions
Publié le 28/04/2026 à 13:30, il y a 20 minutes The Fresh Factory Reports Fiscal 2025 Results with Record Annual Billed Revenue of $45.1M, EBITDA increase of 225% YoY
Publié le 28/04/2026 à 13:30, il y a 20 minutes Eskay Mining Corp. Establishes Rapid Turnaround Analytical Laboratory in Stewart, BC to Accelerate Gold Discovery using detectORE(TM) Technology
Publié le 28/04/2026 à 13:30, il y a 20 minutes Orogen Royalties Reports Record Revenue and Strong Earnings Growth in 2025
Publié le 28/04/2026 à 13:00, il y a 50 minutes Meta Critical Minerals Signs Option Agreement To Acquire High-Grade U.S. Critical Minerals Project Covering Two Historical Deposits Rich in Zircon, Titanium and Rare Earths
Publié le 28/04/2026 à 12:00, il y a 1 heure 50 minutes Dynamite Deploys AI-Powered Identity Technology to Deliver Institutional-Grade Security at Consumer-Level Simplicity
Publié le 28/04/2026 à 13:40, il y a 10 minutes Dahua Technology Releases 2025 ESG Report: Advancing Sustainable Development Through Digital Intelligence
Publié le 28/04/2026 à 13:00, il y a 50 minutes mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics
Publié le 28/04/2026 à 12:31, il y a 1 heure 18 minutes CPI Europe AG – sale of historic building in Prague
Publié le 28/04/2026 à 12:30, il y a 1 heure 20 minutes Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer